Market Pulse59Neutral

Veeva Systems Inc.Opportunity Rank #101(VEEV) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$168.23

Last updated: May 08, 2026

Price vs Intrinsic Value

$168.23
Price
$262.80
Intrinsic Value
Undervalued by 56%MOS: $210.24

Fundamental Score

90/100
Bullish

Weighted across 6 signals

Narrative Score

55/100
Improving

No change vs previous

Trend Score

20/100
Weak

As of 2026-05-08

The intrinsic value of Veeva Systems Inc. (VEEV) is estimated at $262.80 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $168.23, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 10.58% long-term growth rate and a 9.00% discount rate (calculated: 8.76%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Veeva Systems Inc. (VEEV) is estimated at $262.80 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $168.23, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 10.58% long-term growth rate and a 9.00% discount rate (calculated: 8.76%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$262.80
56.21% upside
20% margin of safety: $210.24
Years: 10Growth Rate: 10.58%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
64.42%
Cost of Capital (estimated)7%
Value StatusCreating Value

The company is earning a higher return on invested capital than it costs to raise that capital — a sign of strong, efficient value creation.

Complete historical ROIC is available with
.

Fundamental Details

90/100
BullishWeighted across 6 signals
DCF Discount
56.2% discount to price
100
FCF Yield
5.2% trailing FCF yield
80
ROIC vs WACC
ROIC 64.4% vs WACC 7.0% (9.2x)
100
Net Debt / FCF
Net cash position
100
Buybacks
Share count growing
30
FCF CAGR (5Y)
20.8% 5Y FCF CAGR
100
Strengths: DCF Discount, FCF Yield. Concerns: Buybacks.

Narrative Details

55/100
Improving
Vs 6-Month Baseline:Low (14th pct)Weighted across 6 recent drivers
Trend: StableConfidence: 91%Updated: 16h ago
Sources: 76 (57 News · 19 Analyst)
Drivers(last 30 days)
16 regulatory scrutiny+0.5
2 upgrade headlines+0.1
39 news sentiment-0.1
Analyst downgrades-0.0
Analyst upgrades+0.0
17 analyst reiterations0.0

Trend Details

20/100
WeakAs of 2026-05-08311 daily bars used
6M Relative Strength vs SPY-52.5%
3M Relative Strength vs SPY-16.2%
Distance from 52-Week High-45.7%
Price vs 21 EMA50 · -0.1%
Price vs 50 EMA28 · -4.5%
21 EMA vs 50 EMA18 · -4.5%
3M RS vs SPY6 · -16.2%
6M RS vs SPY0 · -52.5%
Distance from 52W High9 · -45.7%

Investment Coach

Updated 14h ago
BUYConfidence: 81%
Thesis
Veeva Systems Inc. is undervalued with an estimated fair value 58.4% above its current price, supported by a strong fundamental score of 90 and a ROIC significantly exceeding its cost of capital by 57.4 points. The company also demonstrates healthy free cash flow yield and robust growth prospects, making it a compelling buy.
Key Risk
A key risk is the potential decline in ROIC relative to the cost of capital, which could undermine the company's valuation premium.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Confirm ROIC stays above cost of capital over coming quarters.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 10.58%5 Year CAGR: 20.81%

Free Cash Flow (in millions)

TTM202520242023202220212020201920182017201620152014201320122011
$1,441$1,111$938$794$779$560$440$319$243$151$101$94$44$32$5$5

How Intrinziq Estimates Fair Value

Intrinziq estimates Veeva Systems Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Veeva Systems Inc.Healthcare

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.